• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          Results for “”

          Entry Author Date Location
          Xcelerating Life Sciences San Diego Editors 01/15/20 San Diego
          From Discovery to Clinic: Tools & Techniques to Maximize Biologic Drug Candidate Success Editors 09/19/19 San Diego
          Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3 Sarah de Crescenzo 12/17/18 San Diego
          Xconomy Awards San Diego Editors 11/12/18 San Diego
          Xconomy Presents: Big Data Meets Big Biology Editors 01/30/18 San Diego
          Xconomy EXOME Presents: San Diego Life Sciences 2022 Editors 10/19/17 San Diego
          Xconomy Forum: Human Impact of Innovation Editors 02/09/17 San Diego
          Xconomy Forum: Big Data Meets Big Biology Editors 01/14/16 San Diego
          The Healthcare Summit 2013: Precision Medicine to Precision Management Editors 08/28/13 Boston
          The Napa Summit 2013: New Rules for Growth Editors 04/29/13 San Francisco
          The Napa Summit: Keeping America Growing Editors 04/24/12 San Francisco
          Reinventing Fire with Amory Lovins Editors 03/19/12 San Diego
          Xconomy and Connect present: The Rock Stars of Innovation Editors 01/26/12 San Diego
          Xconomy Forum: San Diego’s Fight Against Diabesity Editors 12/06/10 San Diego
          Xconomy Forum: The Rise of Smart Energy Editors 04/23/10 San Diego
          Page 1 of 1

          Interested in National Events?

          Tell us what kind of events you’d enjoy, and we’ll send you quasi-regular updates. Never spammed or shared.

          Please select at least one category.

          Underwriters and Partners

          Xconomy Insight
          • Biotech Startups: How to Succeed in a COVID-19 World

            Xconomy Insight · Special Report

            Biotech Startups: How to Succeed in a COVID-19 World

            Industry experts explain what it takes to launch a new biotech company

          • Bridging the Diversity Gap with Decentralized Trials

            Sponsored · Whitepaper

            Bridging the Diversity Gap with Decentralized Trials

            How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender

            PRA Health Sciences
          • Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

            Sponsored · Whitepaper

            Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

            How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.

            Medpace

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.